In recent years, there has been a revolution in cancer biology that has changed how we treat patients. For any doctor or scientist who finished school prior to 2005, much of this information is new. This course was designed in response to feedback from both junior and senior faculty seeking a better understanding of basic concepts of cancer genomics, epigenomics, and targeted therapeutics.
As a result of this activity, participants will be expected to improve their practice by:
1. Having a better understanding of the components of the immune system and how they may be used to treat cancer
2. Appreciating what cancer immunotherapeutic techniques may be applicable to their patients with specific cancers
3. Gaining awareness of potential side effects of cancer immunotherapy
4. Learning about ongoing cancer immunotherapy research at MSK, which may help them identify trials for which their patients are eligible, colleagues who can consult on their patients, and potential collaborators in translational research